Adamax
Modified nootropic peptide (Semax family)
An adamantane-modified analog in the Semax family, studied for extended nootropic and neurotrophic effect.
How it works
The adamantane group increases lipophilicity and metabolic stability, which is described as extending central exposure and BDNF-related signaling relative to Semax.
What research has shown
Published evidence is limited to early Russian-language work and analog inference from the Semax literature.
Reported ranges in the literature
Low end
100 mcg daily
Optimal
200 to 300 mcg daily in research reports
High end
500 mcg daily
Frequency reported in the literature: Daily in short courses. Note: Thin evidence base compared with Semax or Selank.
Protocol duration and pairing
Typical study duration
10 to 30 day courses.
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.